This webinar will cover the fundamentals of signal detection, and how these can be augmented by the use of data mining techniques.
In March 2005, the FDA published final guidance on "Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment." This guidance defines the FDA's views on pharmacovigilance concepts, safety signal identification, pharmacoepidemiologic assessment and interpretation of safety signals. This webinar will demonstrate how to meet FDA's requirements for detection of potential signals or trends.
In March 2005, the FDA published final guidance on "Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment." This guidance defines the FDA's views on pharmacovigilance concepts, safety signal identification, pharmacoepidemiologic assessment and interpretation of safety signals. This webinar will demonstrate how to meet FDA's requirements for detection of potential signals or trends.
